Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

Home > Research Institute > Available Trials > A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies (SGNTGT-001)

Disease Types: Lung, Melanoma

Available at: Roanoke

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies (SGNTGT-001)

For More Information:

https://clinicaltrials.gov/ct2/show/NCT04254107?term=A+Phase+1+Study+of+SEA-TGT+%28SGN-TGT%29+in+Subjects+with+Advanced+Malignancies+%28SGNTGT-001%29&draw=2&rank=1